Details
NameSymbolSector
BIOFIL CHEMICALS & PHARMACEUTICALS LIMITEDBIOFILCHEMPharmaceuticals
Open
44.2
High
44.8
Low
43.07
Close
43.68
Volume
10221
Exchange
nse
Time
01/08
Outlook
Score:  

0

Rating:  

RISKY

Candlestick Pattern
Candle pattern of Biofil Chemicals & Pharmaceuticals:  
None
Estimated Stoploss of Biofil Chemicals & Pharmaceuticals: ₹  
44.8
Biofil Chemicals & Pharmaceuticals has a  
Bearishℹ
 pattern. 
Biofil Chemicals & Pharmaceuticals is  
Unpredictableℹ
 in the current trend. 
Trend
Biofil Chemicals & Pharmaceuticals is in  
Sideways trendℹ
. 
Price of Biofil Chemicals & Pharmaceuticals is  
Downℹ
 by  

6.81

%. 
Target
Buy @ 

42.12

Sell @ 

52.2

Volume
The trade volumes of Biofil Chemicals & Pharmaceuticals have become  
Deficientℹ
The volume trend for Biofil Chemicals & Pharmaceuticals is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Biofil Chemicals & Pharmaceuticals is  

Down

 by  

61.87

% 
Valuation
The current market price of Biofil Chemicals & Pharmaceuticals is  
Overvaluedℹ
Financials
Balance
The balance sheet of Biofil Chemicals & Pharmaceuticals is:  

Balanced

Income
The income of Biofil Chemicals & Pharmaceuticals is  

₹ 8cr

 and  

Loss

 is :  

₹ 0cr

(*Mar 2025)

Biofil Chemicals & Pharmaceuticals Losses increased by:  

0

% and Income is Down by:  

42.86

% 

(*Mar 2025)

The income of Biofil Chemicals & Pharmaceuticals is  

₹ 14cr

 and  

Loss

 is :  

₹ 0cr

(*Dec 2024)

Biofil Chemicals & Pharmaceuticals Losses increased by:  

0

% and Income is Up by:  

600

% 

(*Dec 2024)

The income of Biofil Chemicals & Pharmaceuticals is  

₹ 2cr

 and  

Loss

 is :  

₹ 0cr

(*Sep 2024)

Biofil Chemicals & Pharmaceuticals Losses increased by:  

0

% and Income is Down by:  

75

% 

(*Sep 2024)

Cashflow
The cash flow of Biofil Chemicals & Pharmaceuticals is  
Poorℹ
. It is  
Downℹ
 by  

200

%. 

(*Mar 2025)

100% operatingℹ
0% investingℹ
0% financingℹ
0% otherℹ
By using this site you agree to the use of cookies to deliver a better site experience.